KNDI Stock UPDATES Kandi Technolgies (KNDI) 18.57 08/10/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kandi Technolgies (KNDI) 18.57 $KNDI

Stocks Sag In Rising Trade; Archer Daniels And Avis Rise
at Investor's Business Daily - Tue Aug 05, 9:39AM CDT
Stocks stubbornly held their opening losses Tuesday, despite some strong factory orders and service-sector data. The Nasdaq and S&P 500 dipped 0.5% each. The Dow Jones industrial average slipped 3%. Small caps lagged the pack, with the Russell 2000...

Major Indexes Extend Losses; S&P 500 Breaks 50-Day Line
at Investor's Business Daily - Thu Jul 31, 10:50AM CDT
Stocks lost more ground near the midpoint of Thursday's session. They had been under pressure from the start amid Argentina's debt default and mixed economic data. The Nasdaq slumped 1.6%, hurt by software and chip stocks. The S&P 500 dropped 1.3%,...

Kandi Technologies Group, Inc.: On-Street EV Charging/Parking Stations Added to Hangzhou Car-Share Program Network
GlobeNewswire - Wed Jul 30, 9:07AM CDT
Kandi Technologies Group, Inc. (the "Company" or "Kandi" (Nasdaq:KNDI), today announced that, due to the high demand for EV charging and parking facilities in Hangzhou city, Zhejiang province in China, on-street EV charging/parking stations have been added to the Hangzhou Car-Share Program network to meet the needs of the Car-Share Program participants. Zhejiang ZuoZhongYou Electric Vehicle Service Co., Ltd. (the "Service Company" or "ZZY" owns and runs the Car-Share Program. The Company, through its 50% ownership interest in Kandi Electric Vehicles Group Co., Ltd. (the "JV Company" , indirectly holds a 9.5% interest in the Service Company.

Kandi Technolgies Up 20.8% Since SmarTrend Uptrend Call (KNDI)
Comtex SmarTrend(R) - Tue Jul 29, 11:17AM CDT
SmarTrend identified an Uptrend for Kandi Technolgies (NASDAQ:KNDI) on June 17th, 2014 at $13.77. In approximately 1 month, Kandi Technolgies has returned 20.77% as of today's recent price of $16.63.

5 of Last Week's Biggest Losers
Rick Munarriz, The Motley Fool - Motley Fool - Sun Jul 27, 11:30AM CDT
There's never a shortage of stocks going the wrong way in any given chunk of time. No stock goes straight up, and sometimes fundamentals can get a bit wobbly. Let's take a closer look at five of this past week's biggest sinkers. Company ...

Nasdaq stocks posting largest percentage decreases
AP - Thu Jul 24, 5:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

Today's Dead Cat Bounce Stock: Kandi Technologies Group (KNDI)
at The Street - Thu Jul 24, 8:52AM CDT
Trade-Ideas LLC identified Kandi Technologies Group (KNDI) as a "dead cat bounce" (down big yesterday but up big today) candidate

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kandi Technologies Group, Inc. - KNDI
PR Newswire - Wed Jul 23, 3:20PM CDT
NEW YORK, July 23, 2014 Pomerantz LLP is investigating claims on behalf of investors of Kandi Technologies Group, Inc. ("Kandi" or the "Company" (NASDAQ: KNDI). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.

Kandi Technolgies Has Returned 61.2% Since SmarTrend Recommendation (KNDI)
Comtex SmarTrend(R) - Tue Jul 22, 9:41AM CDT
SmarTrend identified an Uptrend for Kandi Technolgies (NASDAQ:KNDI) on June 17th, 2014 at $13.77. In approximately 1 month, Kandi Technolgies has returned 61.20% as of today's recent price of $22.20.

Critical Alerts For Kandi Technologies, EMC, Royal Dutch Shell, 3M, and Altria Released By InvestorsObserver
PR Newswire - Tue Jul 22, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for KNDI, EMC, RDS.A, MMM, and MO.

China News Moves Yum, McDonald's, Baidu And Kandi
at Investor's Business Daily - Mon Jul 21, 5:17PM CDT
News poured out of China on Monday, sending a handful of China-related stocks both up and down sharply. Yum Brands (YUM) and McDonald's (MCD) received the short straw Monday, as a new food safety scare in China gained momentum. Both companies issued...

Why Plug Power, Kandi Technologies, and Glu Mobile Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Mon Jul 21, 4:15PM CDT
With no economic data on the table today investors' eyes were clearly focused on what's going on around the globe, and used that uncertainty to push the S&P 500 modestly lower on the day. The two big concerns for investors revolve around...

Look for Shares of Kandi Technolgies to Potentially Pullback after Yesterday's 10.09% Rise
Comtex SmarTrend(R) - Mon Jul 21, 4:10PM CDT
Kandi Technolgies (NASDAQ:KNDI) traded in a range yesterday that spanned from a low of $20.53 to a high of $22.22. Yesterday, the shares gained 10.1%, which took the trading range above the 3-day high of $20.94 on volume of 9.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Glu Mobile, Kandi Technologies Surge; BlackBerry Adds New COO
Sam Mattera, The Motley Fool - Motley Fool - Mon Jul 21, 10:36AM CDT
The Dow Jones Industrial Average was down more than 87 points as of 11:35 a.m. EDT. Despite the move lower in the broader markets, tech stocks  Glu Mobile and Kandi Technologies surged to start the week.  BlackBerry was down on hiring news....

Stocks Open Low And Soft; Baidu, Kandi, Diamondback Rise
at Investor's Business Daily - Mon Jul 21, 9:28AM CDT
Stocks slipped out of the starting gate in weak trade Monday. The Nasdaq and the Dow Jones industrial average ebbed 0.5% each. The S&P 500 slipped 0.4%. The stock market today showed volume down 30% on the Nasdaq and a fraction lower on the NYSE...

5 of Last Week's Biggest Winners
Rick Munarriz, The Motley Fool - Motley Fool - Sun Jul 20, 6:00AM CDT
It was a rough week on Wall Street, with the market moving lower, but there were plenty of individual stocks still pushing higher. Let's take a closer look at five of this past week's biggest scorchers. Company July 18 Weekly...




Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

IONQ Achieves Record Stock Levels Amid Strong Growth Indicators

Updated Category News Views 243

IONQ Stock Reaches New Heights Recently, IONQ has made headlines as its stock skyrocketed to an unprecedented level of $47.41, marking a significant achievement for the company. With a robust market capitalization of $10.2 billion, this remarkable performance is a testament to the company's impressive growth trajectory and the strong belief investors hold in its future....

Continue Reading
Model 1 Commercial Vehicles Expands Leadership Team for Growth

Updated Category News Views 285

Model 1 Commercial Vehicles Announces Leadership Changes Model 1 Commercial Vehicles is thrilled to unveil a set of key leadership appointments aimed at enhancing its strategic direction and ensuring the company's ongoing success. These changes reflect the impressive growth trajectory the company has experienced over the past few years. Tony Matijevich Takes the Helm as...

Continue Reading
Texas Instruments: Unusual Options Trends Uncovered

Updated Category News Views 195

Texas Instruments Options Insights Financial powerhouses have made a notable bullish move on Texas Instruments. Our analysis reveals intriguing trends within the options market for Texas Instruments (NASDAQ: TXN), showcasing an unusual number of trades that pinpoint shifting market sentiments. Trading Sentiment Overview Diving deeper into the data, it appears that 58% of...

Continue Reading
SMCP Unveils Latest Interim Financial Report for 2025

Updated Category News Views 177

SMCP Announces Availability of Its Interim Financial Report SMCP is excited to share that its interim financial report for the six-month period ending June 30, 2025, is now available for public access. This report has been officially filed with the relevant regulatory authorities. Details on the Financial Report This financial report outlines the company's performance...

Continue Reading
Kevin O'Leary Discusses Business Leaders' Support for Trump

Updated Category News Views 159

Understanding O'Leary's Perspective on Business Leadership Kevin O’Leary, a prominent entrepreneur and investor from Shark Tank, has provided insight into the evolving relationship between business leaders and President Trump. In recent discussions, O’Leary emphasized that the admiration many tech CEOs and corporate leaders have for Trump is not solely about his tax...

Continue Reading